Jeff AbbeyCEO at RNativesSpeaker
Profile
Jeff Abbey joined RNatives as CEO in May 2025. He brings over two decades of leadership experience in the biopharmaceutical industry with a successful track record in company building, business development, and fundraising across both public and private global markets. Jeff spent over 16 years at Argos Therapeutics, raising over $250 million in equity financings, including an IPO on NASDAQ, and completing numerous partnering transactions with international biopharmaceutical companies.
Agenda Sessions
Leveraging AI/ML-powered RNAIntel platform to develop precision small RNA gene regulating therapies
, 12:30pmView Session